Page last updated: 2024-10-28

hydroxychloroquine and Tuberculosis, Miliary

hydroxychloroquine has been researched along with Tuberculosis, Miliary in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Tuberculosis, Miliary: An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alemu, A3
Bitew, ZW3
Seid, G3
Diriba, G3
Gashu, E3
Berhe, N3
Mariam, SH3
Gumi, B3

Reviews

1 review available for hydroxychloroquine and Tuberculosis, Miliary

ArticleYear
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc

2022
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc

2022
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc

2022
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Adult; Azithromycin; COVID-19; Female; Humans; Hydroxychloroquine; Latent Tuberculosis; Male; Tuberc

2022